 STAMFORD, Conn.--BUSINESS WIRE--- CMLF AI--Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, and CM Life Sciences Nasdaq: CMLF, a special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, today announced the filing of the preliminary proxy statement related to their proposed business combination. The filing of the preliminary proxy statement initiates the formal Securitie 